174 related articles for article (PubMed ID: 37240352)
1. Soluble ST2 in Patients with Carotid Artery Stenosis-Association with Plaque Morphology and Long-Term Outcome.
Stojkovic S; Kampf S; Harkot O; Nackenhorst M; Brekalo M; Huber K; Hengstenberg C; Neumayer C; Wojta J; Demyanets S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240352
[TBL] [Abstract][Full Text] [Related]
2. Soluble ST2 levels are not associated with secondary cardiovascular events and vulnerable plaque phenotype in patients with carotid artery stenosis.
Willems S; Quax PH; de Borst GJ; de Vries JP; Moll FL; de Kleijn DP; Hoefer IE; Pasterkamp G
Atherosclerosis; 2013 Nov; 231(1):48-53. PubMed ID: 24125409
[TBL] [Abstract][Full Text] [Related]
3. IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study.
Shen J; Shang Q; Wong CK; Li EK; Wang S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Yu SL; Kuan WP; Yu CM; Tam LS
Semin Arthritis Rheum; 2015 Aug; 45(1):18-27. PubMed ID: 25798875
[TBL] [Abstract][Full Text] [Related]
4. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
5. IL-33/IL-33R in various types of carotid artery atherosclerotic lesions.
Stankovic M; Ljujic B; Babic S; Maravic-Stojkovic V; Mitrovic S; Arsenijevic N; Radak D; Pejnovic N; Lukic ML
Cytokine; 2019 Aug; 120():242-250. PubMed ID: 31132589
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
[TBL] [Abstract][Full Text] [Related]
7. Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome.
Demyanets S; Speidl WS; Tentzeris I; Jarai R; Katsaros KM; Farhan S; Krychtiuk KA; Wonnerth A; Weiss TW; Huber K; Wojta J
PLoS One; 2014; 9(4):e95055. PubMed ID: 24751794
[TBL] [Abstract][Full Text] [Related]
8. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
[TBL] [Abstract][Full Text] [Related]
9. Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2.
Shen J; Shang Q; Wong CK; Li EK; Kun EW; Cheng IT; Li M; Li TK; Zhu TY; Yu CM; Qin L; Tam LS
Sci Rep; 2016 Aug; 6():32116. PubMed ID: 27554830
[TBL] [Abstract][Full Text] [Related]
10. [Early detection of asymptomatic carotid disease in patients with obliterative arteriosclerosis of the lower extremities].
Rancić Z; Radak D; Stojanović D
Srp Arh Celok Lek; 2002; 130(7-8):258-64. PubMed ID: 12585003
[TBL] [Abstract][Full Text] [Related]
11. Correlation of plasma soluble suppression of tumorigenicity-2 level with the severity and stability of coronary atherosclerosis.
Zhang Y; Fan Z; Liu H; Ma J; Zhang M
Coron Artery Dis; 2020 Nov; 31(7):628-635. PubMed ID: 32040025
[TBL] [Abstract][Full Text] [Related]
12. The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
Liu N; Hang T; Gao X; Yang W; Kong W; Lou Q; Yang J
PLoS One; 2020; 15(9):e0238775. PubMed ID: 32886697
[TBL] [Abstract][Full Text] [Related]
13. Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2.
Somuncu MU; Kalayci B; Avci A; Akgun T; Karakurt H; Demir AR; Avci Y; Can M
Horm Mol Biol Clin Investig; 2020 Feb; 41(2):. PubMed ID: 32112700
[TBL] [Abstract][Full Text] [Related]
14. Elevated EMMPRIN Serum Levels Indicate Plaque Vulnerability in Patients With Asymptomatic High Grade Carotid Stenosis.
Kampf S; Micko A; Stojkovic S; Nackenhorst M; Demyanets S; Eilenberg WH; Krenn C; Wojta J; Neumayer C
Eur J Vasc Endovasc Surg; 2023 Apr; 65(4):474-483. PubMed ID: 36529365
[TBL] [Abstract][Full Text] [Related]
15. Association of Carotid Artery Plaque With Cardiovascular Events and Incident Coronary Artery Calcium in Individuals With Absent Coronary Calcification: The MESA.
Mehta A; Rigdon J; Tattersall MC; German CA; Barringer TA; Joshi PH; Sperling LS; Budoff MJ; Bertoni A; Michos ED; Blaha MJ; Stein JH; Shapiro MD
Circ Cardiovasc Imaging; 2021 Apr; 14(4):e011701. PubMed ID: 33827231
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of soluble ST2 in adults with congenital heart disease.
Geenen LW; Baggen VJM; van den Bosch AE; Eindhoven JA; Cuypers JAAE; Witsenburg M; Boersma E; Roos-Hesselink JW
Heart; 2019 Jul; 105(13):999-1006. PubMed ID: 30700520
[TBL] [Abstract][Full Text] [Related]
17. Different ST2 Serum Concentrations in Asymptomatic and Symptomatic Carotid Artery Stenosis.
Taurino M; Dito R; Salerno G; De Giusti M; Cirombella R; Ficarelli R; Rizzo L; Del Porto F
Ann Vasc Surg; 2019 Apr; 56():240-245. PubMed ID: 30339898
[TBL] [Abstract][Full Text] [Related]
18. Using Soluble ST2 to Predict Adverse Postoperative Outcomes in Patients with Impaired Left Ventricular Function Undergoing Coronary Bypass Surgery.
Dolapoglu A; Avci E; Yildirim T; Kadi H; Celik A
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31500243
[No Abstract] [Full Text] [Related]
19. A lipid-poor plaque and asymptomatic status in women are associated with higher peak systolic velocity on duplex ultrasound after carotid endarterectomy.
Vrijenhoek JE; de Borst GJ; den Ruijter HM; Merckelbach SM; de Kleijn DP; Pasterkamp G; Moll FL
Atherosclerosis; 2014 Dec; 237(2):677-83. PubMed ID: 25463105
[TBL] [Abstract][Full Text] [Related]
20. Soluble ST2 is a biomarker for cardiovascular mortality related to abnormal glucose metabolism in high-risk subjects.
Cardellini M; Rizza S; Casagrande V; Cardolini I; Ballanti M; Davato F; Porzio O; Canale MP; Legramante JM; Mavilio M; Menghini R; Martelli E; Farcomeni A; Federici M
Acta Diabetol; 2019 Mar; 56(3):273-280. PubMed ID: 30259114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
